Rimsys and QualiZeal Announce Strategic Partnership for Quality Engineering Transformation

QualiZeal to provide Test Advisory, Quality Engineering, Test Automation and Quality Governance & Management services to Rimsys IRVING, Texas–(BUSINESS WIRE)–#DigitalQualityEngineering–QualiZeal, a leading Digital Quality Engineering services company, announced strategic long-term partnership with Pittsburgh-based Rimsys, the leading and only holistic RIM software for MedTech. Rimsys has chosen QualiZeal to help enable their desire to build superior … [Read more…]

The Worldwide Synthetic Biology Industry is Expected to Reach $37.8 Billion by 2028 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Synthetic Biology Market Forecast to 2028 – COVID-19 Impact and Global Analysis by Products, Technology, and Application” report has been added to ResearchAndMarkets.com’s offering. The global synthetic biology market is expected to grow from US$ 10,544.16 million in 2021 to US$ 37,850.85 million by 2028; it is estimated to grow at a … [Read more…]

Pfizer Invites Public to View and Listen to a Webcast of Pfizer Discussion on Expanding Access & Affordability

NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a live webcast at 3:45 p.m. EDT on Monday, June 6, 2022, with Angela Hwang, Group President, Pfizer Biopharmaceuticals Group, and Aamir Malik, Chief Business Innovation Officer, Executive Vice President, who will discuss expanding access and affordability to … [Read more…]

Insights on the Skin Grafting System Global Market to 2028 – Featuring Zimmer Biomet, Stryker and Humeca Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Skin Grafting System Market Forecast to 2028 – COVID-19 Impact and Global Analysis by Product Type, Type, Wound Type, and End User” report has been added to ResearchAndMarkets.com’s offering. The skin grafting system market is projected to reach US$ 1,348.21 million by 2028 from US$ 832.44 million in 2021; it is estimated … [Read more…]

Worldwide Frozen Tissues Samples Industry to 2028 – Increasing Application of Frozen Tissue Samples due to Rising Prevalence of Cancer – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Frozen Tissues Samples Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Product Type, Application and End User” report has been added to ResearchAndMarkets.com’s offering. The frozen tissues samples market is projected to reach US$ 105,045.91 Thousand by 2028 from US$ 44,399.07 Thousand in 2021; it is estimated to grow at … [Read more…]

St. Peter’s Health Moves to the Innovaccer Health Cloud to Optimize Care Management and Collaboration Across Care Sites

Regional integrated health system chooses the Innovaccer 2022 Best in KLAS data platform to provide solutions for enhanced provider-patient collaboration and patient engagement. SAN FRANCISCO–(BUSINESS WIRE)–Today, Innovaccer Inc., the Health Cloud company, announced that St. Peter’s Health, a regional nonprofit healthcare system in Helena, Montana, is moving to the InnovaccerⓇ Health Cloud’s Data Activation Platform … [Read more…]

Global Photoacoustic Tomography Market Forecast to 2028 – COVID-19 Impact and Analysis – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Photoacoustic Tomography Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Geometry, Type, Application and End User” report has been added to ResearchAndMarkets.com’s offering. The photoacoustic tomography market is projected to reach US$ 209.56 million by 2028 from US$ 61.12 million in 2021; it is expected to grow at a CAGR … [Read more…]

Oncomatryx Announces FDA and AEMPS IND Clearance for OMTX705, a First-in-class Tumor Microenvironment-targeted ADC, to Treat Advanced Solid Tumors

BILBAO, Spain–(BUSINESS WIRE)–After 15 years of pioneering R&D efforts in the tumor microenvironment, Oncomatryx announces that the FDA and the Spanish Drug Agency (AEMPS) have cleared its investigational new drug (IND) application for OMTX705, a First-in-Class antibody-drug conjugate (ADC) targeting the tumor microenvironment. OMTX705 is a pioneering ADC that targets, with a novel, dual mechanism … [Read more…]

AXIS Combines Supplemental Health and Corporate Accident Business Units and Signals Ambitions for Growth with Launch of AXIS Group Benefits

PEMBROKE, Bermuda–(BUSINESS WIRE)–$AXS #insurance–AXIS Insurance, the specialty insurance business segment of AXIS Capital Holdings Limited (“AXIS Capital”) (NYSE: AXS), today announced it is combining its corporate accident and supplemental health benefits business under a new name, AXIS Group Benefits. The AXIS Group Benefits business portfolio will be managed by the newly expanded team, providing a … [Read more…]

Lucence Showcases Promising Data on ctDNA and ctRNA Liquid Biopsy Assay for Lung Cancer at 2022 ASCO Annual Meeting

Company to present on extended applications of ultrasensitive liquid biopsy assays at 2022 ASCO in Chicago CHICAGO–(BUSINESS WIRE)–#asco–Lucence, the precision oncology company pioneering ultrasensitive liquid biopsy tests using circulating tumor DNA (ctDNA) and circulating tumor RNA (ctRNA), will present promising new data on the extension of its amplicon-based next generation sequencing (NGS) assays to new … [Read more…]